Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine

Trends in Microbiology

Volumn 9, Issue 10, 2001, Pages 475-480

  Kuwata, Takeo ^a   Miura, Tomoyuki ^a   Hayami, Masanori ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE; VIRUS ENVELOPE PROTEIN;

CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; GENE DELETION; GENE REPLICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IN VIVO STUDY; MACACA; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTECTION; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION;

AIDS VACCINES; ANIMALS; DISEASE MODELS, ANIMAL; GENE DELETION; HIV INFECTIONS; HIV-1; HUMANS; MACACA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TREATMENT OUTCOME; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 0035476488     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(01)02164-3     Document Type: Review

References (53)

1. IAVI advances AIDS vaccine research. International AIDS Vaccine Initiative
2. Vaccines
3. Live virus vaccines
4. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
5. Protective immunity induced by live attenuated simian immunodeficiency virus
6. Live attenuated SIV - A model of a vaccine for AIDS
7. Live attenuated AIDS vaccines: Hazards and hopes
8. Prospects for live attenuated HIV
9. Progress in the development of an HIV-1 vaccine
10. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques
11. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques
12. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence
13. AIDS vaccine trials in chimpanzees
14. Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus
15. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1
16. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells
17. Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus
18. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication
19. A new approach to AIDS research and prevention: The use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines
20. SIV/HIV-1 chimeric viruses having HIV-1 env gene: A new animal model and a candidate for attenuated live vaccine
21. Gene-mutated HIV-1/SIV chimeric viruses as AIDS live attenuated vaccines for potential human use
22. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: A potential candidate live-attenuated human AIDS vaccine
23. Infectivity and immunogenicity of SIVmac/HIV-1 chimeric viruses (SHIVs) with deletions in two or three genes (vpr, nef and vpx)
24. Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus
25. Chimeric viruses between SIVmac and various HIV-1 isolates have biological properties that are similar to those of the parental HIV-1
26. Utility of SHIV for testing HIV-1 vaccine candidates in macaques
27. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
28. HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: Compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates
29. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys
30. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV)
31. Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: Persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques
32. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina)
33. + T cells and AIDS in pig-tailed macaques
34. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS- like disease after in vivo passage in rhesus monkeys
35. Characterization of less pathogenic infectious molecular clones derived from acute-pathogenic SHIV-89.6p stock virus
36. Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD4(+) T-cell depletion in macaques infected by a simian-human immunodeficiency virus
37. Importance of the nef gene for maintenance of high virus loads and for development of AIDS
38. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus
39. Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys
40. HIV-1 envelope-specific CD4+ T helper cells from simian/human immunodeficiency virus-infected rhesus monkeys recognize epitopes restricted by MHC class II DRB1*0406 and DRB*W201 molecules
41. Nonhuman primate spumavirus infections among persons with occupational exposure - United States, 1996
42. Simian immunodeficiency virus needlestick accident in a laboratory worker
43. Brief report: Infection of a laboratory worker with simian immunodeficiency virus
44. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs
45. Protective immunity of gene-deleted SHIVs having an HIV-1 Env against challenge infection with a gene-intact SHIV
46. Sequential analysis of apoptosis induction in peripheral blood mononuclear cells and lymph nodes in the early phase of pathogenic and nonpathogenic SIVmac infection
47. + cells in SHIV-infected macaques
48. A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques
49. Induction of AIDS by simian immunodeficiency virus from an African green monkey: Species-specific variation in pathogenicity correlates with the extent of in vivo replication
50. Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region
51. AIDS as a zoonosis: Scientific and public health implications
52. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease
53. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease